Author

Carolyn Grove

PathWest and Sir Charles Gairdner Hospital - Cited by 2,628 - Leukaemia - molecular diagnostics

Biography

Dr Grove is a clinical and laboratory haematologist at Sir Charles Gairdner Hospital and PathWest. She cares for patients with both malignant and non-malignant haematological disorders.
Title
Cited by
Year
Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis
T McKerrell, N Park, T Moreno, CS Grove, H Ponstingl, J Stephens, ...Cell reports 10 (8), 1239-1245, 2015201
486
2015
Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis
T McKerrell, N Park, T Moreno, CS Grove, H Ponstingl, J Stephens, ...Cell reports 10 (8), 1239-1245, 2015201
484
2015
Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
CS Grove, GS VassiliouDisease models & mechanisms 7 (8), 941-951, 2014201
231
2014
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia
MWM Kühn, E Song, Z Feng, A Sinha, CW Chen, AJ Deshpande, ...Cancer discovery 6 (10), 1166-1181, 2016201
173
2016
Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
MA Dawson, EJ Gudgin, SJ Horton, G Giotopoulos, E Meduri, S Robson, ...Leukemia 28 (2), 311-320, 2014201
168
2014
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype
A Clipson, M Wang, L De Leval, M Ashton-Key, A Wotherspoon, ...Leukemia 29 (5), 1177-1185, 2015201
166
2015
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice
A Mupo, L Celani, O Dovey, JL Cooper, C Grove, R Rad, P Sportoletti, ...Leukemia 27 (9), 1917-1920, 2013201
96
2013
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia
OM Dovey, JL Cooper, A Mupo, CS Grove, C Lynn, N Conte, RM Andrews, ...Blood, The Journal of the American Society of Hematology 130 (17), 1911-1922, 2017201
61
2017
Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies
T McKerrell, T Moreno, H Ponstingl, N Bolli, JML Dias, G Tischler, ...Blood, The Journal of the American Society of Hematology 128 (1), e1-e9, 2016201
58
2016
Genome-wide transposon screening and quantitative insertion site sequencing for cancer gene discovery in mice
MJ Friedrich, L Rad, IF Bronner, A Strong, W Wang, J Weber, M Mayho, ...Nature protocols 12 (2), 289-309, 2017201
51
2017
PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice
J Weber, J de la Rosa, CS Grove, M Schick, L Rad, O Baranov, A Strong, ...Nature Communications 10 (1), 1415, 2019201
44
2019
Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol
N Bolli, N Manes, T McKerrell, J Chi, N Park, G Gundem, MA Quail, ...Haematologica 100 (2), 214, 2015201
43
2015
Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib
SJ Taylor, JM Duyvestyn, SA Dagger, EJ Dishington, CA Rinaldi, ...Science translational medicine 9 (402), eaam8060, 2017201
38
2017
Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture
N Conte, I Varela, C Grove, N Manes, K Yusa, T Moreno, ...Leukemia 27 (9), 1820-1825, 2013201
34
2013
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia
IS Tiong, R Dillon, A Ivey, JA Kuzich, N Thiagarajah, KM Sharplin, CH Kok, ...Blood advances 5 (23), 5107-5111, 2021202
19
2021
Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis
BB Guo, MD Linden, KA Fuller, M Phillips, B Mirzai, L Wilson, H Chuah, ...British journal of haematology 188 (2), 272-282, 2020202
19
2020
Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice
SJ Taylor, CBF Thien, SA Dagger, JM Duyvestyn, CS Grove, BH Lee, ...Experimental hematology 43 (3), 191-206. e1, 2015201
18
2015
Myeloid somatic mutation panel testing in myeloproliferative neoplasms
DM Ross, C Thomson, N Hamad, SW Lane, K Manos, AP Grigg, B Guo, ...Pathology 53 (3), 339-348, 2021202
11
2021
Cerebral arterial and venous thrombosis due to COVID-19 vaccine-induced immune thrombotic thrombocytopenia
E Pang, S Ghosh, T Chemmanam, C Grove, T PhillipsBMJ Case Reports CP 15 (1), e245445, 2022202
10
2022
Effect of olutasidenib (FT-2102) on complete remissions in patients with relapsed/refractory (R/R) mIDH1 acute myeloid leukemia (AML): Results from a planned …
S De Botton, KWL Yee, C Recher, A Wei, P Montesinos, D Taussig, ...Journal of Clinical Oncology 39 (15_suppl), 7006-7006, 2021202
8
2021

Referred From: https://scholar.google.com.au/citations?user=p0mpe70AAAAJ&hl=en

Cited by
Citations 2628
h-index 19
i10-index 26
Recommended Journals
Open Access Journals